Wayne M. Koch

Active 1990–2025

113
Papers
27,396
Citations
88
h-index
110
i10-index

Citations

Citations per year for Wayne M. Koch1989: 1 citations1992: 1 citations1993: 1 citations1994: 18 citations1995: 50 citations1996: 97 citations1997: 89 citations1998: 138 citations1999: 181 citations2000: 179 citations2001: 225 citations2002: 231 citations2003: 243 citations2004: 215 citations2005: 186 citations2006: 182 citations2007: 156 citations2008: 247 citations2009: 212 citations2010: 220 citations2011: 238 citations2012: 225 citations2013: 273 citations2014: 270 citations2015: 194 citations2016: 175 citations2017: 211 citations2018: 166 citations2019: 610 citations2020: 637 citations2021: 572 citations2022: 447 citations2023: 327 citations2024: 417 citations2025: 179 citations2026: 1 citations1990–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,830 citing papers, 33.5% of this breakdownChina: 568 citing papers, 6.7% of this breakdownUnited Kingdom: 488 citing papers, 5.8% of this breakdownGermany: 442 citing papers, 5.2% of this breakdownItaly: 405 citing papers, 4.8% of this breakdownCanada: 285 citing papers, 3.4% of this breakdownFrance: 268 citing papers, 3.2% of this breakdownIndia: 245 citing papers, 2.9% of this breakdownJapan: 238 citing papers, 2.8% of this breakdownNetherlands: 238 citing papers, 2.8% of this breakdownAustralia: 224 citing papers, 2.6% of this breakdownSpain: 199 citing papers, 2.3% of this breakdown
0%33.5%Other 24%

Fields

  • Medicine58.1%
  • Biochemistry, Genetics and Molecular Biology28.5%
  • Immunology and Microbiology5.8%
  • Dentistry4.7%
  • Computer Science0.4%
  • Engineering0.4%
  • Other2.1%

Topics

  • Head and Neck Cancer Studies12%
  • Cancer Genomics and Diagnostics4%
  • Oral Health Pathology and Treatment3.9%
  • Cancer-related Molecular Pathways3.5%
  • Cervical Cancer and HPV Research2.8%
  • Epigenetics and DNA Methylation2.8%
  • Other71%

Coauthors

All papers

Open in search
  1. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 441

  2. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

    Authors: , , , , , , , , - The Journal of Experimental Medicine 2006 cited by 754

  3. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bert Vogelstein, Nishant Agrawal - Science Translational Medicine 2015 cited by 502

  4. Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey N. Myers - Science 2011 cited by 1,702

  5. TP53Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2007 cited by 826

  6. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment

    Authors: , , , , , , , , , , , , , , , - Oncotarget 2016 cited by 318

  7. Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer

    Authors: , , , , , , , - New England Journal of Medicine 2007 cited by 2,691

  8. Saliva and Plasma Quantitative Polymerase Chain Reaction–Based Detection and Surveillance of Human Papillomavirus–Related Head and Neck Cancer

    Authors: , , , , , , , , - JAMA Otolaryngology–Head & Neck Surgery 2014 cited by 240

  9. Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer

    Authors: , , , , , , , , - Oral Oncology 2022 cited by 64

  10. HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Oncogene 2020 cited by 99

  11. Genetic progression model for head and neck cancer: implications for field cancerization.

    Authors: , , , , , , , , , , - 1996 cited by 1,370

  12. Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2015 cited by 184

  13. Increasing prevalence of human papillomavirus–positive oropharyngeal cancers among older adults

    Authors: , , , , , , , , , , , , , - Cancer 2018 cited by 164

  14. Detection of Transcriptionally Active High-risk HPV in Patients With Head and Neck Squamous Cell Carcinoma as Visualized by a Novel E6/E7 mRNA In Situ Hybridization Method

    Authors: , , , , , , , , - The American Journal of Surgical Pathology 2012 cited by 344

  15. High-resolution microbiome profiling uncoversFusobacterium nucleatum,Lactobacillus gasseri/johnsonii, andLactobacillus vaginalisassociated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation

    Authors: , , , , , , , , , , , , , , , , , , , , - Oncotarget 2017 cited by 93

  16. Nutritional Status as a Predictive Biomarker for Immunotherapy Outcomes in Advanced Head and Neck Cancer

    Authors: , , , , , , , , , , , , , , , , , - Cancers 2021 cited by 49

  17. Microsatellite alterations in serum DNA of head and neck cancer patients

    Authors: , , , , - Nature Medicine 1996 cited by 658

  18. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer

    Authors: , , , , , , , , , , , , , - Cancer 2017 cited by 236

  19. Key tumor suppressor genes inactivated by “greater promoter” methylation and somatic mutations in head and neck cancer

    Authors: , , , , , , , , , , , , , , , , - Epigenetics 2014 cited by 147

  20. NID2 and HOXA9 Promoter Hypermethylation as Biomarkers for Prevention and Early Detection in Oral Cavity Squamous Cell Carcinoma Tissues and Saliva

    Authors: , , , , , , , , , , , , , , , , , - Cancer Prevention Research 2011 cited by 146

  21. Priorities, concerns, and regret among patients with head and neck cancer

    Authors: , , , , , , , , , - Cancer 2019 cited by 86

  22. GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , - Science Signaling 2020 cited by 40

  23. Head and neck squamous cell carcinoma cell lines: Established models and rationale for selection

    Authors: , , , , , , , - Head & Neck 2006 cited by 271

  24. Inverse Relationship between Human Papillomavirus-16 Infection and Disruptivep53Gene Mutations in Squamous Cell Carcinoma of the Head and Neck

    Authors: , , , , , - Clinical Cancer Research 2008 cited by 232